75
Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT- P Benjamin J. Krakauer, MPA, NREMT-P

Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Embed Size (px)

Citation preview

Page 1: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Presentation Prepared ByJames L. Dean, AEMT-P and Sean J. Britton, NREMT-P

Benjamin J. Krakauer, MPA, NREMT-P

Page 2: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

SREMS ALS Protocol Update

Questions arising from the application of the protocols should be addressed to your medical control physician, Agency Medical Director, or to the Susquehanna Regional Medical Emergency Advisory Committee (SREMS REMAC).

Page 3: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Definitions

“Infant” is considered up to 1 year of age.“Child” is considered 1 year of age to the onset

of puberty (12-14 year old). “Adult” is considered the age of puberty (12-14

years old) and upwards.

Page 4: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 5: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 6: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 7: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Prepare for success:•Identify if the patient will be a difficult intubation.•Position the patient.•Have suction turned on and well within reach.•Ensure your IV access is patent.•Have a King airway ready.•Practice intubation on a manikin regularly to maintain competency.

Page 8: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Versed (Midazolam)• Class: short acting benzodiazepine, CNS depressant• Description: benzodiazepine frequently used for conscious

sedation• Mechanism of action: suppresses the spread of electrical activity

through the cortex of the brain. Reduces anxiety/stress and induces amnesia.

• Administration: Adult – 2.5mg slow IV • Indications: premedication for intubation, maintenance of

sedation• Contraindications: Hypersensitivity Hypotension Glaucoma

Respiratory depression• Side Effects: Respiratory depression Nausea/vomiting Headache

Blurred vision Cough Hypotension• Precautions/Interactions: sedative effect increases with

concomitant use of barbiturates, alcohol, and narcotics

Page 9: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Recordable Waveform Capnography

• Verify placement on all adult and pediatric patients with direct visualization, auscultation, and waveform capnography.

• Waveform Capnography is considered to be the “Gold Standard” method of verifying ETT placement.

Page 10: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Definitive Confirmation & Continuous Monitoring

– Continuous End Tidal CO2 waveform capnography monitoring. The capnography device must have the ability to print and/or store the data of the continuous waveform monitoring documentation as well as QA/QI purposes. The ability to print the data should be accomplished at the hospital when ever possible.

– Print a copy of the strip from the LP12 and scan this into your e-pcr for documented proof.

Page 11: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

This protocol has been changed to allow Ondansetron (Zofran) to be administered IV or IM This was a change from IV only.

Page 12: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 13: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 14: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Altered Mental Status causes:AlcoholEpilepsyInsulinOverdoseUremiaTraumaInfectionPsychosesStroke: There has been a separate Stroke Protocol added.

Page 15: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Remember to ascertain time of onset of symptoms.Consider air transport based on location and time of onset.

Page 16: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Albuterol Sulfate 0.083%, 2.5 mg in 3ml mixed with Ipratropium 0.5mg (one unit dose) via nebulizer at a flow rate of 6 LPM.

(EMT-CC/EMT-P) may repeat x1

IV Epinephrine 1:10,000 dose is now 1mg.

Page 17: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 18: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 19: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 20: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 21: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Albuterol Sulfate0.083%, 2.5 mg in 3ml mixed with Ipratropium 0.5mg(one unit dose) via nebulizer at a flow rate of 6 LPM O2 (EMT-CC/EMT-P) first nebulizer treatment .

Page 22: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Albuterol Sulfate 0.083%, 2.5 mg in 3ml mixed with Ipratropium 0.5mg (one unit dose) via nebulizer at a flow rate of 6 LPM O2 for first nebulizer treatment.

Medical Control Options.

Nitro Paste has been added as a Med Control option for CHF.

Page 23: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Atrovent (Ipratropium)• Class: Bronchodilator• Description: Anticholinergic used in the treatment of

asthma/COPD• Mechanism of action: Antagonizes acetylcholine receptor

producing bronchodilatation• Administration: Administer via nebulization along with Albuterol• Indications: Treatment of bronchospasm from asthma,

anaphylaxis, or COPD• Contraindications: • Hypersensitivity Acute glaucoma Caution if prostatic

hypertrophy• Side Effects: • Glaucoma Tachycardia Dizziness Headache Dry

mouth• Precautions/Interactions: caution with bladder obstruction

Page 24: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 25: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 26: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 27: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 28: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 29: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

MORPHINE is a standing order for Pain Management due to Burns:

Morphine Sulfate IV/IM 5mg may repeat to a max of 10mg

Med Control Signature REQUIRED!!!

Page 30: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

MORPHINE is a standing order for Pain Management due to Fractures/Dislocations

Morphine Sulfate IV/IM 5mg may repeat to a max of 10mg

Med Control Signature REQUIRED!!!

Toradol has been REMOVED!!!

Page 31: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Spinal shock causes hypotension which may require a large amount of fluid infusion.

Page 32: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

The dose of Lidocaine prior to intubation with signs of increased ICP is:

1 – 1.5 mg/kg with a Maximum of 100mg.

Page 33: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 34: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 35: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 36: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 37: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 38: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 39: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

100 ml over 10 minutes =10 gtts/sec with 60 gtts/ml set.

Page 40: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 41: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 42: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 43: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 44: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 45: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 46: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 47: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 48: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 49: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

12 Lead ECG is now a separate protocol!!

Page 50: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 51: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 52: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 53: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 54: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 55: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 56: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 57: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 58: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 59: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 60: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 61: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 62: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 63: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 64: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 65: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Albuterol Sulfate 0.083%, 2.5 mg in 3ml mixed with Ipratropium 0.5mg (one unit dose) via nebulizer at a flow rate of 6 LPM O2

EMT-CCT, EMT-P

Page 66: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P

Diazepam dose is per Broselow Tape recommendation

Medical Control signature is REQUIRED

Page 67: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 68: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 69: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 70: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 71: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 72: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 73: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 74: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P
Page 75: Presentation Prepared By James L. Dean, AEMT-P and Sean J. Britton, NREMT-P Benjamin J. Krakauer, MPA, NREMT-P